PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas.

@article{Sattar2006PETIT,
  title={PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas.},
  author={Tanvir Humayun Sattar and Landis K. Griffeth and Hamid R. Latifi and Jun Joseph Edward Glass and Reinhold Munker and David L. Lilien},
  journal={The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society},
  year={2006},
  volume={158 4},
  pages={
          193-201
        }
}
Malignant non-Hodgkin lymphomas (NHLs) are commonly staged according to the Ann Arbor staging system developed for Hodgkin's lymphoma. Recently, new staging modalities including metabolic imaging by positron emission tomography (PET) using F-18 fluorodeoxy-glucose (FDG) have been developed. In the present study, we investigated 77 untreated patients with different histologies of NHL both with conventional imaging techniques and FDG-PET. The patients were classified according to the World Health… CONTINUE READING